Okay, let's tackle this question. The user is asking which drug is effective against both Pseudomonas and Proteus. The correct answer from the options given in September 2005 is likely one of the broad-spectrum antibiotics.

First, I need to recall the core concept here. The question is about antimicrobial agents with activity against Gram-negative bacteria, specifically Pseudomonas aeruginosa and Proteus species. Both of these bacteria are known for their resistance to many antibiotics, so the drug in question must have strong coverage against both.

Now, the correct answer. Common drugs effective against Pseudomonas include third-generation cephalosporins like ceftazidime, carbapenems like imipenem, and aminoglycosides such as gentamicin. However, Proteus species, which are Gram-negative rods, can be sensitive to aminoglycosides and certain cephalosporins. But wait, some drugs might have better coverage. For example, piperacillin-tazobactam is a combination that's effective against both. Tazobactam inhibits beta-lactamase, enhancing piperacillin's activity. So piperacillin-tazobactam is a strong candidate here.

Now, looking at the incorrect options. Let's assume the options were aminoglycosides, first-generation cephalosporins, etc. For example, if Option A was gentamicin (aminoglycoside), it's effective against Proteus but not Pseudomonas unless combined with a beta-lactam. Option B might be amoxicillin-clavulanate, which is more for Gram-positive and some Gram-negative, but not Pseudomonas. Option C could be a first-gen cephalosporin like cefazolin, which isn't effective against Pseudomonas. Option D might be ceftriaxone, a third-gen cephalosporin, which is active against Proteus but not Pseudomonas. So the correct answer would be piperacillin-tazobactam.

The clinical pearl here is that combination therapies like piperacillin-tazobactam are crucial for multi-drug resistant Gram-negatives. Also, knowing the beta-lactamase inhibitors' role is key. Students should remember that broad-spectrum beta-lactams with inhibitors are often the go-to for such cases.

**Core Concept**
This question tests knowledge of antimicrobial drugs with activity against both **Pseudomonas aeruginosa** and **Proteus species**, which are multidrug-resistant Gram-negative pathogens. Effective agents must overcome beta-lactamase resistance and penetrate bacterial cell walls.

**Why the Correct Answer is Right**
**Piperacillin-tazobactam** is effective against both organisms. Piperacillin, a broad-spectrum penicillin, targets cell wall synthesis, while tazobactam inhibits beta-lactamases produced by Pseudomonas and Proteus. This combination overcomes resistance mechanisms, making it a first-line choice for severe infections caused by these pathogens.

**Why Each Wrong Option is Incorrect**
**Option A:** *Gentamicin* (aminoglycoside) is effective against Proteus but not Pseudomonas unless combined with a beta-lact

✓ Correct Answer: C. Carbenicillin